187 related articles for article (PubMed ID: 36356998)
21. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
[TBL] [Abstract][Full Text] [Related]
22. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
[TBL] [Abstract][Full Text] [Related]
23. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
Mathur R; Rentsch CT; Morton CE; Hulme WJ; Schultze A; MacKenna B; Eggo RM; Bhaskaran K; Wong AYS; Williamson EJ; Forbes H; Wing K; McDonald HI; Bates C; Bacon S; Walker AJ; Evans D; Inglesby P; Mehrkar A; Curtis HJ; DeVito NJ; Croker R; Drysdale H; Cockburn J; Parry J; Hester F; Harper S; Douglas IJ; Tomlinson L; Evans SJW; Grieve R; Harrison D; Rowan K; Khunti K; Chaturvedi N; Smeeth L; Goldacre B;
Lancet; 2021 May; 397(10286):1711-1724. PubMed ID: 33939953
[TBL] [Abstract][Full Text] [Related]
24. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
25. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
26. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
Bertran M; Amin-Chowdhury Z; Davies HG; Allen H; Clare T; Davison C; Sinnathamby M; Seghezzo G; Kall M; Williams H; Gent N; Ramsay ME; Ladhani SN; Oligbu G
PLoS Med; 2022 Nov; 19(11):e1004118. PubMed ID: 36346784
[TBL] [Abstract][Full Text] [Related]
28. United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.
Teece L; Gray LJ; Melbourne C; Orton C; Ford DV; Martin CA; McAllister D; Khunti K; Tobin M; John C; Abrams KR; Pareek M;
BMJ Open; 2021 Jun; 11(6):e046392. PubMed ID: 34183342
[TBL] [Abstract][Full Text] [Related]
29. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.
Schnier C; McCarthy A; Morales DR; Akbari A; Sofat R; Dale C; Takhar R; Mamas MA; Khunti K; Zaccardi F; Sudlow CL; Wilkinson T;
Lancet Healthy Longev; 2023 Aug; 4(8):e421-e430. PubMed ID: 37543047
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
32. Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study.
Evans A; Qi C; Adebayo JO; Underwood J; Coulson J; Bailey R; Lyons R; Edwards A; Cooper A; John G; Akbari A
J Infect; 2023 Apr; 86(4):352-360. PubMed ID: 36773891
[TBL] [Abstract][Full Text] [Related]
33. Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
Wallace S; Hall V; Charlett A; Kirwan PD; Cole M; Gillson N; Atti A; Timeyin J; Foulkes S; Taylor-Kerr A; Andrews N; Shrotri M; Rokadiya S; Oguti B; Vusirikala A; Islam J; Zambon M; Brooks TJG; Ramsay M; Brown CS; Chand M; Hopkins S
BMJ Open; 2022 Jun; 12(6):e054336. PubMed ID: 35768083
[TBL] [Abstract][Full Text] [Related]
34. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
36. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
HDR UK COALESCE Consortium
Lancet; 2024 Feb; 403(10426):554-566. PubMed ID: 38237625
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).
Foret-Bruno P; Shafran R; Stephenson T; Nugawela MD; Chan D; Ladhani S; McOwat K; Mensah A; Simmons R; Fox Smith L; D'oelsnitz A; Xu L; Dalrymple E; Heyman I; Ford T; Segal T; Chalder T; Rojas N; Pinto Pereira SM;
Brain Behav Immun; 2024 Jul; 119():989-994. PubMed ID: 38735404
[TBL] [Abstract][Full Text] [Related]
38. Impact of the COVID-19 pandemic on domiciliary care workers in Wales, UK: a data linkage cohort study using the SAIL Databank.
Cannings-John R; Schoenbuchner S; Jones H; Lugg-Widger FV; Akbari A; Brookes-Howell L; Hood K; John A; Thomas DR; Prout H; Robling M
BMJ Open; 2023 Jun; 13(6):e070637. PubMed ID: 37263685
[TBL] [Abstract][Full Text] [Related]
39. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
